These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10586048)

  • 21. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
    Terayama R; Bando Y; Yamada M; Yoshida S
    Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
    Spach KM; Pedersen LB; Nashold FE; Kayo T; Yandell BS; Prolla TA; Hayes CE
    Physiol Genomics; 2004 Jul; 18(2):141-51. PubMed ID: 15138306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection from autoimmunity by DNA vaccination against T-cell receptor.
    Buch T; Waisman A
    Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
    Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
    J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of myelin oligodendrocyte glycoprotein and myelin basic protein in the thymus and central nervous system and its relationship to the clinicopathologic features of autoimmune encephalomyelitis.
    Sakuma H; Park IK; Kohyama K; Feng D; Matsumoto Y
    J Neurosci Res; 2006 Aug; 84(3):606-13. PubMed ID: 16773652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis.
    Read RW; Szalai AJ; Vogt SD; McGwin G; Barnum SR
    Exp Eye Res; 2006 Mar; 82(3):389-94. PubMed ID: 16143328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion.
    Liedtke W; Edelmann W; Chiu FC; Kucherlapati R; Raine CS
    Am J Pathol; 1998 Jan; 152(1):251-9. PubMed ID: 9422542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
    Daugherty DJ; Chechneva O; Mayrhofer F; Deng W
    Sci Rep; 2016 Mar; 6():22556. PubMed ID: 26925573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.
    Brambilla R; Persaud T; Hu X; Karmally S; Shestopalov VI; Dvoriantchikova G; Ivanov D; Nathanson L; Barnum SR; Bethea JR
    J Immunol; 2009 Mar; 182(5):2628-40. PubMed ID: 19234157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
    Kang HJ; Bao L; Xu Y; Quigg RJ; Giclas PC; Holers VM
    Clin Exp Immunol; 2004 May; 136(2):194-9. PubMed ID: 15086380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Ramaglia V; Jackson SJ; Hughes TR; Neal JW; Baker D; Morgan BP
    Clin Exp Immunol; 2015 Jun; 180(3):432-41. PubMed ID: 25619542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression.
    Barnum SR; Jones JL; Müller-Ladner U; Samimi A; Campbell IL
    Glia; 1996 Oct; 18(2):107-17. PubMed ID: 8913774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization Techniques for miRNA Expression in Low Frequency Immune Cell Populations.
    Lyons VG; Payne NL; McCoy CE
    Methods Mol Biol; 2018; 1725():237-256. PubMed ID: 29322422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis.
    Orr EL
    Ann N Y Acad Sci; 1988; 540():723-6. PubMed ID: 3207302
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases.
    Xu L; Xu H; Chen S; Jiang W; Afridi SK; Wang Y; Ren X; Zhao Y; Lai S; Qiu X; Alvin Huang YW; Cui Y; Yang H; Qiu W; Tang C
    Mol Ther; 2023 Sep; 31(9):2715-2733. PubMed ID: 37481702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.